Inhibiting FABP5 represents a unique mechanism of action with ART26.12 standing out as a first ... including TRPV1, PPAR alpha, and cannabinoid receptors, with additional mechanisms such as Nav1.8 ...

Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in ...

Researchers from the Universidade do Porto have identified promising anti-cancer properties in four lesser-known cannabinoids ...

In this week’s edition of InnovationRx, we look at the health impact of the Republican spending bill, a startup that built a hospital in India to test its AI software, the impact of the vaccine panel ...

Operationalising de-addiction centres and implementing inclusive policies are critical to addressing the escalating substance abuse emergency in the region S ...

CRB-913 is an oral small molecule inverse agonist of the G-protein Coupled Receptor (GPCR) cannabinoid type-1 (CB1). This is a recognized mechanism of action for weight loss, but the previous class of ...

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

Patients and caregivers said the emergency rules were incomplete in some areas and too strict in others, which they said ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

The changes are part Microsoft's efforts to improve the resiliency of the Windows operating system after last year’s ...

The defects in molecular and cellular processes that constitute the triggers of specific pathologies are referred to as mechanisms of disease. Research in this area is vital for designing ...

Inhaled cannabinoids have been shown to perform better than placebo in providing pain relief for people suffering from acute migraine, according to a new clinical trial. In the study, researchers ...